ConductScience.org, home

Paper100810

The practical significance of nortriptyline plasma control. A prospective evaluation under routine conditions in endogenous depression.

Sørensen B and 3 others. Psychopharmacology (Berl), 1978. Cited by 37 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The practical significance of nortriptyline plasma control. A prospective evaluation under routine conditions in endogenous depression. Papers, record 100810. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/100810

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The practical significance of nortriptyline plasma control. A prospective evaluation under routine conditions in endogenous depression.
PubMed
Journal
Psychopharmacology (Berl)
PubMed
Year
1978
PubMed
Publication types
Clinical Trial, Journal Article
PubMed
Citations, by iCite
37
iCite
Relative citation ratio, by iCite
2.4
iCite
Revised in PubMed
2019-07-26
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sørensen BB
2Kragh-Sørensen PP
3Larsen NEN E
4Hvidberg EFE F

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DepressionMajor topic
NortriptylineMajor topic
Aged
Clinical Trials as Topic
Female
Humans
Male
Middle Aged

Source PubMed

References13

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14,824,200The efficacy of antidepressant drugs. A review of research (1958-1972).Arch Gen Psychiatry1974https://conductscience.org/library/papers/4824200PubMed
24,118,463Plasma-nortriptyline levels in endogenous depression.Lancet1973https://conductscience.org/library/papers/4118463PubMed
3981,330Therapeutic control of plasma concentrations and long-term effect of nortriptyline in recurrent affective disorders.Pharmakopsychiatr Neuropsychopharmakol1976https://conductscience.org/library/papers/981330PubMed
4766,041Self-inhibiting action of nortriptylin's antidepressive effect at high plasma levels: a randomized double-blind study controlled by plasma concentrations in patients with endogenous depression.Psychopharmacologia1976https://conductscience.org/library/papers/766041PubMed
54,208,380Long-term treatment of endogenous depression with nortriptyline with control of plasma levels.Psychol Med1974https://conductscience.org/library/papers/4208380PubMed
6871,827Routine nortriptyline levels in treatment of depression.Br Med J1977https://conductscience.org/library/papers/871827PubMed
74,950,568A pharmacokinetic approach to the treatment of depression.Int Pharmacopsychiatry1971https://conductscience.org/library/papers/4950568PubMed
8860,894A comparison study of amitriptyline and nortriptyline with plasma levels.Arch Gen Psychiatry1977https://conductscience.org/library/papers/860894PubMed
94,762,222International reliability and communicability of a rating scale for depression.Psychol Med1973https://conductscience.org/library/papers/4762222PubMed
10869,057Relationship between age and tricyclic antidepressant plasma levels.Am J Psychiatry1977https://conductscience.org/library/papers/869057PubMed
11788,992Nortriptyline plasma levels and therapeutic response.Clin Pharmacol Ther1976https://conductscience.org/library/papers/788992PubMed
125,558,186Relationship between plasma level and therapeutic effect of nortriptyline.Br Med J1971https://conductscience.org/library/papers/5558186PubMed
1310,583Treatment of depression with tricyclic drugs--pharmacokinetic and pharmacodynamic aspects.Pharmakopsychiatr Neuropsychopharmakol1976https://conductscience.org/library/papers/10583PubMed

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.

PMIDTitleJournalYearIn PapersSource
26,849,844Exploratory Biomarker Study of the Triple Reuptake Inhibitor SEP-432 Compared to the Dual Reuptake Inhibitor Duloxetine in Healthy Normal Subjects.CNS Neurosci Ther2016https://conductscience.org/library/papers/26849844PubMed
19,277,699Trifluoperazine: a rynodine receptor agonist.Pflugers Arch2009https://conductscience.org/library/papers/19277699PubMed
6,812,139Amitriptyline and nortriptyline response profiles in unipolar depressed patients.Psychopharmacology (Berl)1982https://conductscience.org/library/papers/6812139PubMed
6,499,343Prediction of steady-state nortriptyline plasma levels by the repeated one-point method.Clin Pharmacokinet1984https://conductscience.org/library/papers/6499343PubMed
6,412,270The demethylation of amitriptyline: a cross-over study of steady-state plasma levels of amitriptyline and nortriptyline in depressed patients.Psychopharmacology (Berl)1983https://conductscience.org/library/papers/6412270PubMed
6,114,851Current antidepressant drugs: their clinical use.Drugs1981https://conductscience.org/library/papers/6114851PubMed
42,101Interaction between amitriptyline and phenothiazine in man: effect on plasma concentration of amitriptyline and its metabolite nortriptyline and the correlation with clinical response.Psychopharmacology (Berl)1979https://conductscience.org/library/papers/42101PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/100810

GET https://conductscience.org/api/papers/v1/100810/authors